首页> 外文OA文献 >Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China
【2h】

Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China

机译:中国上海氟喹诺酮耐药结核分枝杆菌临床分离株的分子特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

China is one of the countries with the highest prevalence of fluoroquinolone-resistant (FQ r) Mycobacterium tuberculosis. Nevertheless, knowledge on the molecular characterization of the FQ r M. tuberculosis strains of this region remains very limited. This study was performed to investigate the frequencies and types of mutations present in FQ r M. tuberculosis clinical isolates collected in Shanghai, China. A total of 206 FQ r M. tuberculosis strains and 21 ofloxacin-sensitive (FQ s) M. tuberculosis strains were isolated from patients with pulmonary tuberculosis in Shanghai. The phenotypic drug susceptibilities were determined by the proportion method, and the mutations inside quinolone resistance-determining region (QRDR) of gyrA and gyrB genes were identified by DNA sequence analyses. Among 206 FQ r M. tuberculosis strains, 44% (90/206) were multidrug-resistant isolates and 39% (81/206) were extensively drug-resistant isolates. Only 9% (19/206) were monoresistant to ofloxacin. In total, 79.1% (163/206) of FQ r isolates harboured mutations in either gyrA or gyrB QRDR. Mutations in gyrA QRDR were found in 75.7% (156/206) of FQ r clinical isolates. Among those gyrA mutants, a majority (75.6%) harboured mutations at amino acid position 94, with D94G being the most frequent amino acid substitution. Mutations in gyrA QRDR showed 100% positive predictive value for FQ r M. tuberculosis in China. Mutations in gyrB were observed in 15.5% (32/206) of FQ r clinical isolates. Ten novel mutations were identified in gyrB. However, most of them also harboured mutations in gyrA, limiting their contribution to FQ r resistance in M. tuberculosis. Our findings indicated that, similar to other geographic regions, mutations in gyrA were shown to be the major mechanism of FQ r resistance in M. tuberculosis isolates. The mutations in gyrA QRDR can be a good molecular surrogate marker for detecting FQ r M. tuberculosis in China. © 2012 Elsevier Inc.
机译:中国是耐氟喹诺酮(FQ r)结核分枝杆菌感染率最高的国家之一。然而,关于该区域的FQ r结核分枝杆菌菌株的分子表征的知识仍然非常有限。这项研究的目的是调查在中国上海收集的FQ r。M.结核病临床分​​离株中存在的突变的频率和类型。从上海的肺结核患者中共分离出206株FQ r结核分枝杆菌和21株氧氟沙星敏感(FQ s)结核分枝杆菌。通过比例法确定表型药物敏感性,并通过DNA序列分析鉴定gyrA和gyrB基因的喹诺酮抗性决定区(QRDR)内部的突变。在206株FQ r结核分枝杆菌菌株中,有44%(90/206)是耐多药菌株,而39%(81/206)是广泛耐药菌。只有9%(19/206)对氧氟沙星单抗。总共有79.1%(163/206)的FQ r分离株在gyrA或gyrB QRDR中带有突变。在FQ r临床分离株的75.7%(156/206)中发现了gyrA QRDR突变。在这些gyrA突变体中,大多数(75.6%)在94位氨基酸处具有突变,其中D94G是最常见的氨基酸取代。 gyrA QRDR突变显示中国FQ r。M.结核病的100%阳性预测值。在FQ r临床分离株的15.5%(32/206)中观察到gyrB突变。在gyrB中鉴定出十个新突变。然而,它们中的大多数还含有gyrA突变,从而限制了它们对结核分枝杆菌FQ r耐药性的贡献。我们的发现表明,与其他地理区域类似,gyrA突变被证明是结核分枝杆菌分离株对FQ r耐药的主要机制。 gyrA QRDR中的突变可以作为检测中国FQ r。M.结核病的良好分子替代标记。 ©2012爱思唯尔公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号